Nurix Therapeutics CSO sells 4,111 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. Chief Scientific Officer Gwenn Hansen reported selling a total of 4,111 shares of common stock on 2026-08-04 in two transactions at weighted average prices of $23.8684 and $24.6415. The sales were effected pursuant to a previously adopted Rule 10b5-1 trading plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,500 | $23.8684 | $36K |
| Sale | Common Stock F1, F3 | 2,611 | $24.6415 | $64K |
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $23.42 and the highest price at which shares were sold was $24.38. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. Represents the weighted average sale price. The lowest price at which shares were sold was $24.43 and the highest price at which shares were sold was $24.83. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
Sale in open market or private transaction regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nurix Therapeutics (NRIX) report in this Form 4?
Were the NRIX insider sales by Gwenn Hansen under a Rule 10b5-1 plan?
What is the transaction code used for Gwenn Hansen’s NRIX trades?
Does the Form 4 disclose Gwenn Hansen’s NRIX holdings after these sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.